News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,607 Results
Type
Article (48231)
Company Profile (501)
Press Release (714856)
Multimedia
Podcasts (145)
Webinars (24)
Section
Business (212541)
Career Advice (2181)
Deals (37594)
Drug Delivery (141)
Drug Development (84745)
Employer Resources (177)
FDA (17079)
Job Trends (15570)
News (360754)
Policy (34261)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2775)
Academic (1)
Accelerated approval (50)
Adcomms (31)
Allergies (178)
Alliances (52198)
ALS (221)
Alzheimer's disease (1870)
Antibody-drug conjugate (ADC) (477)
Approvals (17414)
Artificial intelligence (739)
Autoimmune disease (300)
Automation (58)
Bankruptcy (386)
Best Places to Work (11980)
BIOSECURE Act (20)
Biosimilars (227)
Biotechnology (348)
Bladder cancer (191)
Brain cancer (77)
Breast cancer (771)
Cancer (5994)
Cardiovascular disease (498)
Career advice (1856)
Career pathing (46)
CAR-T (344)
CDC (61)
Celiac Disease (3)
Cell therapy (955)
Cervical cancer (48)
Clinical research (73102)
Collaboration (2186)
Company closure (5)
Compensation (1412)
Complete response letters (91)
COVID-19 (2862)
CRISPR (117)
C-suite (1162)
Cystic fibrosis (162)
Data (7958)
Decentralized trials (3)
Denatured (46)
Depression (176)
Dermatology (86)
Diabetes (599)
Diagnostics (7197)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (362)
Drug pricing (215)
Drug shortages (33)
Duchenne muscular dystrophy (301)
Earnings (93944)
Editorial (72)
Employer branding (21)
Employer resources (157)
Events (124468)
Executive appointments (1124)
FDA (20863)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1802)
Gene editing (256)
Generative AI (65)
Gene therapy (790)
GLP-1 (1134)
Government (4953)
Grass and pollen (6)
Guidances (410)
Healthcare (19643)
HIV (87)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (323)
Immuno-oncology (99)
Indications (191)
Infectious disease (3211)
Inflammatory bowel disease (232)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (295)
Interviews (347)
IPO (17094)
IRA (54)
Job creations (3928)
Job search strategy (1537)
JPM (67)
Kidney cancer (19)
Labor market (99)
Layoffs (616)
Leadership (43)
Legal (8341)
Liver cancer (101)
Longevity (33)
Lung cancer (789)
Lymphoma (435)
Machine learning (60)
Management (61)
Manufacturing (1084)
MASH (195)
Medical device (14308)
Medtech (14429)
Mergers & acquisitions (21754)
Metabolic disorders (1580)
mRNA (234)
Multiple sclerosis (194)
NASH (20)
Neurodegenerative disease (444)
Neuropsychiatric disorders (118)
Neuroscience (3463)
Neurotech (1)
NextGen: Class of 2026 (6916)
Non-profit (4716)
Now hiring (78)
Obesity (755)
Opinion (325)
Ovarian cancer (224)
Pain (259)
Pancreatic cancer (308)
Parkinson's disease (379)
Partnered (35)
Patents (605)
Patient recruitment (690)
Peanut (64)
People (61894)
Pharmaceutical (87)
Pharmacy benefit managers (34)
Phase 1 (22973)
Phase 2 (32216)
Phase 3 (23836)
Pipeline (8738)
Policy (337)
Postmarket research (2659)
Preclinical (9944)
Press Release (70)
Prostate cancer (307)
Psychedelics (64)
Radiopharmaceuticals (343)
Rare diseases (1149)
Real estate (6344)
Recruiting (71)
Regulatory (26510)
Reports (58)
Research institute (2585)
Resumes & cover letters (371)
Rett syndrome (39)
RNA editing (26)
RSV (90)
Schizophrenia (188)
Series A (309)
Series B (224)
Service/supplier (12)
Sickle cell disease (120)
Special edition (29)
Spinal muscular atrophy (172)
Sponsored (52)
Startups (3906)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (88)
The Weekly (96)
Vaccines (1145)
Venture capital (117)
Weight loss (496)
Women's health (127)
Worklife (21)
Date
Today (189)
Last 7 days (939)
Last 30 days (3673)
Last 365 days (31599)
2026 (12649)
2025 (31766)
2024 (36792)
2023 (41338)
2022 (52615)
2021 (57168)
2020 (55590)
2019 (48261)
2018 (36374)
2017 (33727)
2016 (33232)
2015 (39217)
2014 (33105)
2013 (28171)
2012 (30174)
2011 (30790)
2010 (28971)
Location
Africa (810)
Alabama (98)
Alaska (7)
Arizona (362)
Arkansas (16)
Asia (42715)
Australia (7096)
California (13515)
Canada (3782)
China (1397)
Colorado (580)
Connecticut (595)
Delaware (407)
Europe (94279)
Florida (1990)
Georgia (431)
Hawaii (3)
Idaho (65)
Illinois (1079)
India (90)
Indiana (610)
Iowa (25)
Japan (542)
Kansas (135)
Kentucky (53)
Louisiana (42)
Maine (75)
Maryland (1617)
Massachusetts (9791)
Michigan (369)
Minnesota (731)
Mississippi (6)
Missouri (157)
Montana (36)
Nebraska (29)
Nevada (144)
New Hampshire (91)
New Jersey (3558)
New Mexico (33)
New York (3522)
North Carolina (1777)
North Dakota (10)
Northern California (6731)
Ohio (410)
Oklahoma (23)
Oregon (46)
Pennsylvania (2692)
Puerto Rico (29)
Rhode Island (51)
South America (1191)
South Carolina (85)
South Dakota (2)
Southern California (5312)
Tennessee (212)
Texas (2140)
United States (47865)
Utah (402)
Vermont (1)
Virginia (330)
Washington D.C. (84)
Washington State (1108)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
763,607 Results for "barrier therapeutics inc acquired by stiefel laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
March 9, 2026
·
9 min read
Gene therapy
FDA approval of Regeneron’s hearing loss gene therapy breaks barriers
Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying cause of the condition.
April 23, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
May 5, 2026
·
5 min read
Press Releases
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline
May 6, 2026
·
6 min read
Press Releases
Assertio Announces Agreement to be Acquired by Garda Therapeutics
April 8, 2026
·
9 min read
Press Releases
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid
April 28, 2026
·
6 min read
Press Releases
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
April 20, 2026
·
6 min read
Press Releases
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
March 27, 2026
·
8 min read
Opinion
Opinion: The Barrier to ALS Precision Drugs Isn’t Science. It’s the ‘Valley of Death’
As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing early-stage research to more quickly bring effective treatments to the market.
March 19, 2026
·
5 min read
·
Bernie Zipprich
Press Releases
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval
April 16, 2026
·
4 min read
1 of 76,361
Next
